Showing results (371-380 of 398) with videos related to
Sort By:
Pageof 40
Journal of Digestive Diseases|May 8, 2020
Agreement of gastroenterologists in traditional Chinese medical differential diagnosis of functional dyspepsia compared with traditional Chinese medical practitioners: A prospective, multicenter studyJun Song, Ling Yang, Shuai Su, et al.Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.The Lancet. Respiratory Medicine|May 23, 2022
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialJing-Xin Li, Shi-Po Wu, Xi-Ling Guo, et al.Lancet (London, England)|March 31, 2015
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trialFeng-Cai Zhu, Li-Hua Hou, Jing-Xin Li, et al.Neurology|April 4, 2025
Triple Antihypertensive Medication Prediction Score After Intracerebral Hemorrhage (the TRICH Score)Ching Hei So, Charming Yeung, Ryan Wui-Hang Ho, et al.Lancet (London, England)|December 27, 2016
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialFeng-Cai Zhu, Alie H Wurie, Li-Hua Hou, et al.Journal of Neurogastroenterology and Motility|May 14, 2013
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation ToolKok-Ann Gwee, Uday C Ghoshal, Sutep Gonlachanvit, et al.Journal of Digestive Diseases|October 11, 2021
Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trialYing Lian Xiao, Ning Dai, Shui Xiang He, et al.Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.The Lancet. Respiratory Medicine|May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre studyTao Huang, Sheng Zhang, De-Fang Dai, et al.Pageof 40